CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation

Osteolytic bone disease is a hallmark of multiple myeloma (MM). A significant fraction (~20%) of MM patients do not develop osteolytic lesions (OLs). The molecular basis for the absence of bone disease in MM is not understood. We combined PET-CT and gene expression profiling (GEP) of purified BM CD1...

Cijeli opis

Bibliografski detalji

Glavni autori:	Dongzheng Gai, Jin-Ran Chen, James P. Stewart, Intawat Nookaew, Hasem Habelhah, Cody Ashby, Fumou Sun, Yan Cheng, Can Li, Hongwei Xu, Bailu Peng, Tarun K. Garg, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Fangping Chen, Bart Barlogie, Frits van Rhee, Guido Tricot, John D. Shaughnessy Jr., Fenghuang Zhan
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Clinical Investigation 2022-09-01
Serija:	The Journal of Clinical Investigation
Teme:	Bone Biology Hematology
Online pristup:	https://doi.org/10.1172/JCI159527
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!